These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8929723)

  • 1. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
    Willems D; Dorchy H; Dufrasne D
    Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) in diabetes mellitus.
    Ritter MM; Loscar M; Richter WO; Schwandt P
    Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
    Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
    Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications.
    Willems D; Dorchy H; Dufrasne D
    Atherosclerosis; 1998 Apr; 137 Suppl():S61-4. PubMed ID: 9694543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
    Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
    Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
    Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.
    Pérez A; Carreras G; Caixàs A; Castellví A; Caballero A; Bonet R; Ordóñez-Llanos J; de Leiva A
    Diabetes Care; 1998 Sep; 21(9):1517-20. PubMed ID: 9727901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for subclinical complications in children and adolescents with type 1 diabetes: experience acquired in Brussels].
    Dorchy H
    Rev Med Brux; 2010; 31(2 Suppl):S87-108. PubMed ID: 21812221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
    Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for subclinical complications in young type 1 diabetic patients: experience acquired in Brussels.
    Dorchy H
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):380-403. PubMed ID: 16437030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
    Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus.
    Westerhuis LW; Venekamp WJ
    Clin Biochem; 1996 Jun; 29(3):255-9. PubMed ID: 8740512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
    Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
    Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
    Nordwall M; Hyllienmark L; Ludvigsson J
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.
    Kapelrud H; Bangstad HJ; Dahl-Jørgensen K; Berg K; Hanssen KF
    BMJ; 1991 Sep; 303(6804):675-8. PubMed ID: 1833011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.